Evaluation of Iyengariastellata for its hypolipidemic and hepatoprotective activity

Pakistan Journal of Pharmaceutical Sciences

Volumn 27, Issue 6, 2014, Pages 1775-1779

  Riaz, Bushra ^a   Najam, Rahila ^b   Anser, Humera ^c   Ali, Muhammad Shaiq ^b  

^a JINNAH UNIVERSITY FOR WOMEN   (Pakistan)

^b UNIVERSITY OF KARACHI   (Pakistan)

^c Jinnah College of Pharmacy   (Pakistan)

Author keywords

Cholesterol; Hepatoprotective; Hypolipidemic; Iyengariastellata; SGPT

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ALGAL EXTRACT; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN; INDICATOR; LIVER ENZYME; LIVER PROTECTIVE AGENT; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN; WATER; ANTILIPEMIC AGENT; LIPID; PROTECTIVE AGENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; EXPERIMENTAL RABBIT; FEMALE; HUMAN; HYPOLIPEMIA; INGESTION; IYENGARIASTELLATA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; MALE; NONHUMAN; SEAWEED; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; DRUG EFFECTS; ENZYMOLOGY; LIVER; RABBIT;

ANIMALS; FEMALE; HYPOLIPIDEMIC AGENTS; LIPIDS; LIVER; MALE; PROTECTIVE AGENTS; RABBITS; SEAWEED;

EID: 84908874384     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ali MS, Viqar Uddin Ahmad, Mazhar F, Azhar I and Khan U (1999). Some chemical constituents from marine algae of Karachi coast (Arabian Sea). Turk. J. Chem., 23: 181-183.
2. Aliya R, Shameel M, Usmanghani K and Ahmed UV (1991). Analysis of fatty acids from codiumiyengar. Pak. J. Pharm. Sci., 4(2): 103-111.
3. Anderson JW, Baird P, Davis RH, Ferreri S, Knudtson M, Koraym A, Waters V and Williams CL (2009). Health benefits of dietary fiber. Nutr. Rev., 67(4): 188-205.
4. Ara J, Sultana V, Qasim R and Ahmad VU (2002). Hypolipidaemic activity of seaweed from Karachi coast. Phytother. Res., 16(5): 479-483.
5. Bhakuni DS and Silva M (1974). Biodynamic substances from marine flora. Bot. Mar., 17: 40-51.
6. Bidel S, Silventoinen K, Hu G, Lee DH, Kaprio J and Tuomilehto J (2008). Coffee consumption, serum gamma-glutamyltransferase and risk of type II diabetes. Eur. J. Clin. Nutr., 62:178-185.
7. Carlson LA, Bottiger LE and Ahfeldt PE (1979). Risk factors for Myocardial infarction in the Stockholm propective study. A. 14 year follow up focusing on the role of plasma triglyceride and cholesterol. Acta. Med. Scand., 206: 351-360.
8. Chunacova EP (1967). Change in the permeability of blood capillaries in patients with coronary atherosclerosis under the effect of an antisclerotic diet. Sov. Med., 30: 30-35.
9. De Bono and Boon NA (1992). Diseases of the cardiovascular system. In Davidson's Principles and practices of Medicine. Eds. Edwards CRW, Bouchier IAD. ELBS Churchill Livingstone: Edinburgh pp.249-340.
10. Giboney PT (2005). Mildly elevated liver transaminase levels in the asymptomatic patient. Am. Fam. Physician., 71(6):1105-1110.
11. Gordon T, Castelli WP, Hjorthland MC, Kannel WB and Dawber TR (1977). High density lipoprotein as a protective factor against coronary heart disease, The Framingham study. Am. J. Med., 62: 707-714.
12. Guven KC, Guler E, Actin E and Koyuncuoglu H (1979). Studies on Pterocaladiacapillacea (Gmel.). Born. Et Thur. Part II. Pharmacological, antibacterial and antifungal investigations. In: Marine algae in pharmaceutical science. Eds. Hoppe HA, Levring T, Tanaka Y. Berlin, New York, W. de Gruyter. pp.693-710.
13. th ed. WB Saunders Company, pp.460-463, 838, 850, 855.
14. Hussein M (1975). Two new polysaccharides from Colpomeniasinuosa. Phytochem., 14: 1866-1868.
15. Hussein M, A Abdel-Aziz and Salem HM (1983). Chemical composition of Colpomeniasinuosaäs influenced by seasonal Variation. Pak. J. Sci. Ind. Res., 26: 152-154.
16. Kaneda T, Tokuda S and Arai K (1963). Studies on the effects of marine products on cholesterol metabolism, 1.The effects of edible seaweed. Bulletin Jap. Soc. Sci. Fish., 29: 1020-1035.
17. Khan AM (2000). Phytochemical and structural studies on the chemical constituents of Taxuswallichiana, Tanacetumgracile, Jolynalaminarioides and other marine algae dissertation, University of Karachi.
18. Lee WM (1995). Drug-induced hepatotoxicity. N. Engl. J. Med., 333: 1118-1127.
19. Martin MJ, Hulley SB, Browner WS, Kuller LH and Wentworth D (1986). Serum cholesterol, blood pressure and mortality. Lancet, 2: 933-936.
20. Mehta BR and Parekh RG (1978). Mannitol content in brown algae of the coast of Saurashtra. Bot. Mar., 21: 251.
21. Murata M, Ishihara K and Saito H (1999). Hepatic fatty acid oxidation enzyme activities are stimulated in rats fed the brown seaweed, Undaria pinnatifida (Wakame). J. Nutr., 129(1): 146-151.
22. Najam R (2003). Pharmacological screening of some bioactive products from marine resources dissertation. University of Karachi.
23. Nyblom H, Bjornsson E, Simren M, Aldenborg F, Almer S and Olsson R (2006). The AST/ALT ratio as an indicator of cirrhosis in patients with PBC. Liver. Int., 26(7): 840-845.
24. Ostlund RE Jr (2007). Phytosterols, cholesterol absorption and healthy diets. Lipids., 42(1): 41-45.
25. Qasim and Rashida (1991). Aminoacid composition of some common seaweeds. Pak. J. Pharm. Sci., 4(1): 49.
26. Qasim R and Barkati S (1985). Ascorbic acid and dehydroascorbic acid contents of marine algal species from Karachi. Pakistan J. Sci. Ind. Res., 28: 129-133.
27. Rizvi MA and Shameel M (2001). Estimation of elements in seaweeds of Karachi coast. Pak. J. Bot., 33: 357-363.
28. Ruttmann E, Brant LJ, Concin H, Diem G and Rapp K et al (2005). Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: An epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation, 112: 2130-2137.
29. Sliskovic DR and White AD (1991). Therapeutoc potential of ACAT inhibitors as lipid lowering and anti-atherosclerotic agents. TIPS., 12: 194-199.
30. Stampfer MJ, Sacks FM, Salvini S, Willett WC and Hennekens CH (1991). A prospective study of cholesterol, apolipoproteins and the risk of myocardial infarction. N. Engl. J. Med., 325(6): 373-381.
31. Strasak AM, Rapp K, Brant LJ, Hilbe W, Gregory M, Oberaigner W, Ruttmann E, Concin H, Diem G, Pfeiffer KP, Ulmer H. and the VHM & PP Study Group (2008). Association of gamma-glutamyltransferase and risk of cancer incidence in men: A prospective study. Cancer Res., 68: 3970-3977.
32. Thompson GR, Naoumova RP and Watts GF (1996). Role of cholesterol in regulating apolipoprotein B secretion by the liver. J. Lipid. Res., 37: 439-447.
33. Trautwein EA, Guus SMJE Duchateau, Lin Y, Mel'nikov SM, Molhuizen HOF and Ntanios FY (2003). Proposed mechanisms of cholesterol-lowering action of plant sterols. Eur. J. Lipid. Sci. Technol., 105(3-4): 171-185.
34. Usmanghani K, Shameel M, Siddiqui S and Siddiqui SA (1987). Studies on the fatty acids of Iyengariastellata (schytosiphonales, pheophyta). Bot. Mar., 30: 305.
35. Velichko MA and Shevchenko VP (1998). Bilologically active food additives. Voen. Med. ZH., 319: 24-27.
36. Vezquez-Friere MJ, Lamela M and Calleja JM (1996). Hypolipidemic activity of a polysaccharide extract from Fucus vesiculosus L. Phytother. Res., 10: 647-650.
37. West KM, Ahuja MMS and Bennet PH (1983). The role circulating glucose and triglyceride concentration and their interaction with other risk factors as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes care., 6: 361-369.
38. Yang X, Kang MC, Lee KW, Kang SM, Lee WW and Jeon YJ (2011). Anti-oxidant activity and cell protective effect of loliolide isolated from Sargassum ringgoldianum subsp. Coreanum. Algae, 26(2): 201-208.